Suchergebnisse - "Halfmann, Peter J"

PubPharm (24)

1

Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine

enthalten in: Nature communications | 2024

von Halfmann, P. | Loeffler, K. | Duffy, A. | +5

UpdateOf: Res Sq. 2023 Jun 29;:. - PMID 37461652

2

Mapping SARS-CoV-2 antigenic relationships and serological responses

enthalten in: Science (New York, N.Y.) | 2023

von Wilks, S. | Mühlemann, B. | Shen, X. | +29

UpdateOf: bioRxiv. 2023 Jun 16;:. - PMID 35860221

3

Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2

enthalten in: Vaccine | 2023

von Chiba, S. | Halfmann, P. | Iida, S. | +7

4

Transmission and re-infection of Omicron variant XBB.1.5 in hamsters

enthalten in: EBioMedicine | 2023

von Halfmann, P. | Uraki, R. | Kuroda, M. | +4

5

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants

enthalten in: The Journal of clinical investigation | 2023

von Changrob, S. | Halfmann, P. | Liu, H. | +24

CommentIn: J Clin Invest. 2023 Apr 17;133(8):. - PMID 37066880

6

Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses

enthalten in: EBioMedicine | 2022

von Halfmann, P. | Frey, S. | Loeffler, K. | +9

7

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant

enthalten in: Science translational medicine | 2022

von Halfmann, P. | Kuroda, M. | Armbrust, T. | +27

8

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

enthalten in: Nature | 2022

von Uraki, R. | Kiso, M. | Iida, S. | +66

UpdateOf: Res Sq. 2022 Feb 24;:. - PMID 35233565

9

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

enthalten in: Nature communications | 2022

von Case, J. | Mackin, S. | Errico, J. | +22

10

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2

enthalten in: Med (New York, N.Y.) | 2022

von Darling, T. | Ying, B. | Whitener, B. | +14